If you are considering GLP-1 medications, such as semaglutide or tirzepatide, to help achieve your weight loss goals, we are here to assist you
doi: 10.1254/jphs.FP0060070
Alcohol can also irritate the stomach, worsening nausea or vomiting caused by semaglutide
Semaglutide in Type 2 Diabetic Adult Patients In a clinical trial, semaglutide showed superiority over dulaglutide to improve glucose control and weight loss greater than 5% in type 2 diabetic adult patients.[12] The study was randomized and open-label, meaning the participants knew what medication they received
A variety of causes, including inadequate nutrition, environmental pollutants, and stress, can lower glutathione levels in the body
Weight loss is known to trigger compensatory biology: Increased appetite signaling Reduced resting energy expenditure Heightened food reward sensitivity Stopping GLP-1 therapy at peak dose, without tapering and without reinforcing lifestyle strategies at the exact moment hunger returns, does not allow lifestyle behaviors to take over. Emerging real-world data and obesity physiology suggest a different, more clinically relevant path: Gradual dose reduction rather than abrupt cessation Continued, structured dietary and exercise support Active monitoring during the high-risk post-cessation period We still need randomized trials designed specifically to test tapering and lifestyle-anchored maintenance strategies
